FTC Release: FTC Stops Proposed Merger of Leading Cataract-Surgery Device Makers
Dow Jones03-24 21:11
Deal threatened to raise prices and reduce innovation for cataract laser eye surgery systems, impacting surgeons and millions of American patients
In response to the announcement that Alcon, Inc. and Alcon Research, LLC (collectively referred to as Alcon) has abandoned its efforts to purchase LENSAR, Inc. (Lensar), Federal Trade Commission Bureau of Competition Director Daniel Guarnera issued the following statement:
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments